These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

750 related articles for article (PubMed ID: 18167337)

  • 1. Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis.
    Yang L; Huang J; Ren X; Gorska AE; Chytil A; Aakre M; Carbone DP; Matrisian LM; Richmond A; Lin PC; Moses HL
    Cancer Cell; 2008 Jan; 13(1):23-35. PubMed ID: 18167337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGFβ signaling in myeloid cells regulates mammary carcinoma cell invasion through fibroblast interactions.
    Shaw AK; Pickup MW; Chytil A; Aakre M; Owens P; Moses HL; Novitskiy SV
    PLoS One; 2015; 10(1):e0117908. PubMed ID: 25629162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of TGF-β signaling in myeloid cells enhances their anti-tumorigenic properties.
    Novitskiy SV; Pickup MW; Chytil A; Polosukhina D; Owens P; Moses HL
    J Leukoc Biol; 2012 Sep; 92(3):641-51. PubMed ID: 22685318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β signaling in myeloid cells is required for tumor metastasis.
    Pang Y; Gara SK; Achyut BR; Li Z; Yan HH; Day CP; Weiss JM; Trinchieri G; Morris JC; Yang L
    Cancer Discov; 2013 Aug; 3(8):936-51. PubMed ID: 23661553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid-specific TGF-β signaling in bone promotes basic-FGF and breast cancer bone metastasis.
    Meng X; Vander Ark A; Lee P; Hostetter G; Bhowmick NA; Matrisian LM; Williams BO; Miranti CK; Li X
    Oncogene; 2016 May; 35(18):2370-8. PubMed ID: 26279296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.
    Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
    Mol Cancer Res; 2008 Oct; 6(10):1521-33. PubMed ID: 18922968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-130a and miR-145 reprogram Gr-1
    Ishii H; Vodnala SK; Achyut BR; So JY; Hollander MC; Greten TF; Lal A; Yang L
    Nat Commun; 2018 Jul; 9(1):2611. PubMed ID: 29973593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gr-1+CD11b+ cells are responsible for tumor promoting effect of TGF-β in breast cancer progression.
    Li Z; Pang Y; Gara SK; Achyut BR; Heger C; Goldsmith PK; Lonning S; Yang L
    Int J Cancer; 2012 Dec; 131(11):2584-95. PubMed ID: 22487809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL17-derived CD11b
    Hsu YL; Yen MC; Chang WA; Tsai PH; Pan YC; Liao SH; Kuo PL
    Breast Cancer Res; 2019 Feb; 21(1):23. PubMed ID: 30755260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of TGF-β signaling in generation of CD39+CD73+ myeloid cells in tumors.
    Ryzhov SV; Pickup MW; Chytil A; Gorska AE; Zhang Q; Owens P; Feoktistov I; Moses HL; Novitskiy SV
    J Immunol; 2014 Sep; 193(6):3155-64. PubMed ID: 25127858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer.
    Bierie B; Chung CH; Parker JS; Stover DG; Cheng N; Chytil A; Aakre M; Shyr Y; Moses HL
    J Clin Invest; 2009 Jun; 119(6):1571-82. PubMed ID: 19451693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromally derived lysyl oxidase promotes metastasis of transforming growth factor-β-deficient mouse mammary carcinomas.
    Pickup MW; Laklai H; Acerbi I; Owens P; Gorska AE; Chytil A; Aakre M; Weaver VM; Moses HL
    Cancer Res; 2013 Sep; 73(17):5336-46. PubMed ID: 23856251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of one Tgfbr2 allele in fibroblasts promotes metastasis in MMTV: polyoma middle T transgenic and transplant mouse models of mammary tumor progression.
    Fang WB; Jokar I; Chytil A; Moses HL; Abel T; Cheng N
    Clin Exp Metastasis; 2011 Apr; 28(4):351-66. PubMed ID: 21374085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.
    Bierie B; Stover DG; Abel TW; Chytil A; Gorska AE; Aakre M; Forrester E; Yang L; Wagner KU; Moses HL
    Cancer Res; 2008 Mar; 68(6):1809-19. PubMed ID: 18339861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-β receptor II loss promotes mammary carcinoma progression by Th17 dependent mechanisms.
    Novitskiy SV; Pickup MW; Gorska AE; Owens P; Chytil A; Aakre M; Wu H; Shyr Y; Moses HL
    Cancer Discov; 2011 Oct; 1(5):430-41. PubMed ID: 22408746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
    Tian H; Liu J; Chen J; Gatza ML; Blobe GC
    Oncogene; 2015 Nov; 34(45):5635-47. PubMed ID: 25823021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway.
    Yoo YA; Kang MH; Kim JS; Oh SC
    Carcinogenesis; 2008 Mar; 29(3):480-90. PubMed ID: 18174246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gr-1+CD11b+ myeloid cells tip the balance of immune protection to tumor promotion in the premetastatic lung.
    Yan HH; Pickup M; Pang Y; Gorska AE; Li Z; Chytil A; Geng Y; Gray JW; Moses HL; Yang L
    Cancer Res; 2010 Aug; 70(15):6139-49. PubMed ID: 20631080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion.
    Sundqvist A; Zieba A; Vasilaki E; Herrera Hidalgo C; Söderberg O; Koinuma D; Miyazono K; Heldin CH; Landegren U; Ten Dijke P; van Dam H
    Oncogene; 2013 Aug; 32(31):3606-15. PubMed ID: 22926518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
    Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY
    Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.